Brief Summary
To conduct a multicenter observational cohort study to determine the variability in fluid resuscitation in shock in a broad range of areas in hospitals and treatment areas.
Brief Title
Variation in Fluids Administered in Shock
Completion Date
Completion Date Type
Actual
Conditions
Shock
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years admitted to the participating hospital.
* Patients in the emergency department, intensive care unit, PACU, or any hospital floor. For patients not in the ICU, there must be plans to transfer to an intensive care unit when an ICU bed is available for patient.
* Patients with shock as defined by:
* Need for vasopressor (dopamine, norepinephrine, or epinephrine at any dose) to keep MAP \> 65 mmHg Or
* Systolic BP \< 90 mmHg
Exclusion Criteria:
* Patients previously enrolled into this study.
* Patients who were in the operating room at time of shock and fluid bolus.
* Patients admitted to an ICU after cardiac surgery Patients with primarily cardiogenic shock as etiology for their shock
* Patients transferred from another hospital or emergency room to the study hospital.
* Age ≥ 18 years admitted to the participating hospital.
* Patients in the emergency department, intensive care unit, PACU, or any hospital floor. For patients not in the ICU, there must be plans to transfer to an intensive care unit when an ICU bed is available for patient.
* Patients with shock as defined by:
* Need for vasopressor (dopamine, norepinephrine, or epinephrine at any dose) to keep MAP \> 65 mmHg Or
* Systolic BP \< 90 mmHg
Exclusion Criteria:
* Patients previously enrolled into this study.
* Patients who were in the operating room at time of shock and fluid bolus.
* Patients admitted to an ICU after cardiac surgery Patients with primarily cardiogenic shock as etiology for their shock
* Patients transferred from another hospital or emergency room to the study hospital.
Inclusion Criteria
Inclusion Criteria:
* Age ≥ 18 years admitted to the participating hospital.
* Patients in the emergency department, intensive care unit, PACU, or any hospital floor. For patients not in the ICU, there must be plans to transfer to an intensive care unit when an ICU bed is available for patient.
* Patients with shock as defined by:
* Need for vasopressor (dopamine, norepinephrine, or epinephrine at any dose) to keep MAP \> 65 mmHg Or
* Systolic BP \< 90 mmHg
* Age ≥ 18 years admitted to the participating hospital.
* Patients in the emergency department, intensive care unit, PACU, or any hospital floor. For patients not in the ICU, there must be plans to transfer to an intensive care unit when an ICU bed is available for patient.
* Patients with shock as defined by:
* Need for vasopressor (dopamine, norepinephrine, or epinephrine at any dose) to keep MAP \> 65 mmHg Or
* Systolic BP \< 90 mmHg
Gender
All
Gender Based
false
Healthy Volunteers
No
Last Update Post Date
Last Update Post Date Type
Actual
Last Update Submit Date
Minimum Age
18 Years
NCT Id
NCT03190408
Org Class
Other
Org Full Name
Montefiore Medical Center
Org Study Id
2017-7860
Overall Status
Completed
Primary Completion Date
Primary Completion Date Type
Actual
Official Title
Observation of Variation in Fluids Administered and Characterization of Vasopressor Requirements in Shock
Primary Outcomes
Outcome Description
Characterize the method used to guide volume resuscitation and vasopressor use in patients with shock
Outcome Measure
Method used to guide volume resuscitation
Outcome Time Frame
7 days
Start Date
Start Date Type
Actual
Status Verified Date
First Post Date
First Post Date Type
Actual
First Submit Date
First Submit QC Date
Study Population
patients with shock
Std Ages
Adult
Older Adult
Maximum Age Number (converted to Years and rounded down)
999
Minimum Age Number (converted to Years and rounded down)
18
Investigators
Investigator Type
Principal Investigator
Investigator Name
Jen-Ting Chen
Investigator Email
jeche@montefiore.org
Investigator Phone
646-229-2304
MeSH Terms
SHOCK
PATHOLOGIC PROCESSES
PATHOLOGICAL CONDITIONS, SIGNS AND SYMPTOMS
FLUID THERAPY
DRUG THERAPY
THERAPEUTICS